Sesderma Dryses Deodorant Recalled for cGMP Deviations
Sesderma is recalling 195 bottles of Dryses Aluminum Chlorohydrate Deodorant for Women due to cGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences. The source text cites cGMP deviations without reporting specific illnesses or injuries, aligning with a moderate severity assessment.
Plain-English summary
Sesderma, SL is recalling 195 bottles of Dryses Aluminum Chlorohydrate Deodorant for Women, Roll-on, 2.5 fl oz (75 mL) bottle. The product is an over-the-counter deodorant manufactured in Valencia, Spain. The recall is being conducted because the product does not comply with current Good Manufacturing Practice (cGMP) requirements.
The affected product is identified by NDC 16047-0029-1. Specific lot codes include 33454701 with an expiration date of 11/18, and lot 40424701 with an expiration date of 1/2019. The product was distributed to the states of Florida, Puerto Rico, Colorado, and Georgia.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- Dryses Aluminum Chlorohydrate Deodorant for Women, Roll-on, 2.5 fl oz (75 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 16047-0029-1
- Manufacturer
- Sesderma, SL
- Category
- Drug — Deodorant
- Hazard
- Affected units
- 195
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot code 33454701
- exp 11/18
- lot 40424701
- exp 1/2019
Distribution
Part of a larger recall action
This product is one of 10 recalled by Sesderma, SL under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Sesderma, SL
See all →- ModerateSesderma Recalls Dryses Antiperspirant Solution for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Salises Acne Gel Recalled for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Sunscreen Recalled for cGMP Non-Compliance
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 50 Sunscreen Due to cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
FDA (Drugs) · 2016-05-18
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14